Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancersRaffit Hassan, Steven J Cohen, Martin Phillips, et al.
Investigational New Drugs|March 27, 2014
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinomaAna De Jesus-Acosta, Daniel Laheru, Anirban Maitra, et al.
Clinical Imaging|November 29, 2024
Role of volumetric tumor enhancement on CT in predicting overall survival in patients with unresectable pancreatic ductal adenocarcinomaSeyedeh Panid Madani, Alireza Mohseni, Mohammad Mirza-Aghazadeh-Attari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I study of ON 01910.Na, a novel modulator of the Polo-like kinase 1 pathway, in adult patients with solid tumorsAntonio Jimeno, Jing Li, Wells A Messersmith, et al.
Investigational New Drugs|February 19, 2008
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreasSteven Attia, Jill Kolesar, Michelle R Mahoney, et al.
Cancer Cell|July 30, 2021
From bench to bedside: Single-cell analysis for cancer immunotherapyEmily F Davis-Marcisak, Atul Deshpande, Genevieve L Stein-O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survivalValeria Sebastiani, Francesca Ricci, Belen Rubio-Viqueira, et al.
Pageof 10